A Study to Learn About the Effect of Nusinersen (BIIB058) Given as Injections to Children With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec (RESPOND)
Clinical trial NCT04488133 · COMPLETED
Trial details
- NCT number
- NCT04488133
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2025-10-09
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.